Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.31 USD | -1.74% | -11.28% | +141.94% |
May. 17 | Vera Therapeutics Insider Sold Shares Worth $1,304,435, According to a Recent SEC Filing | MT |
May. 10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+141.94% | 2.08B | |
+63.12% | 62.59B | |
-2.08% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.21% | 26.21B | |
-21.88% | 19.09B | |
+3.56% | 13.08B | |
+25.49% | 12.26B | |
+27.30% | 12.05B |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Oppenheimer Raises Vera Therapeutics Price Target to $34 From $26, Maintains Outperform Rating